FIB Funding Opportunity Announcements (FOAs) | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development

US Department of Health and Human Services National Institutes of Health Directory Follow

Announcement Number	Submissions Date(s)	Expiration Date	Activity Code(s)	Title
RFA-HD-21-012		July 1, 2020	P50	National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 Clinical Trial Optional)
RFA-HD-20-021	November 26, 2019	November 27, 2019	R21	Fertility and Fertility Preservation for Patients with Diseases that Previously Precluded Reproduction (R21 Clinical Trial Optional)
RFA-HD-20-010	December 3, 2019	December 4, 2019	R43/R44	Technologies to Advance Precision Medicine Diagnosis and Treatment of Infertility, Reproductive Tract and Gynecologic Disorders Affecting Fertility (R43/R44 Clinical Trial Optional)
PA-18-838	Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 5, 2018. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	September 8, 2021	R01	Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R01 - Clinical Trial Optional)
PA-18-839	Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 16, 2018. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	September 8, 2021	R21	Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R21 Clinical Trial Optional)
PAR-18-830	November 7, 2018, June 3, 2019, March 3, 2020, November 7, 2020, June 3, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	June 4, 2021	R01	The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)
PAR-18-831	November 7, 2018, June 3, 2019, March 3, 2020, November 7, 2020, June 3, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	June 4, 2021	R21	The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed)
PA-17-091	Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 5, 2017. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.	May 8, 2020	R01	Fertility Status as a Marker for Overall Health (R01)
PA-16-445	Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.	January 8, 2020	R01	Trophoblast Differentiation and Function (R01)

BACK TO TOP